Advertisement

Topics

Revisiting β-Blockers in Patients with Acute Myocardial Infarction

20:00 EDT 20 Jun 2017 | NEJM

A registry study on patients without heart failure or left ventricular systolic dysfunction shows no effect on mortality but does not provide guidance for treatment decisions.

Original Article: Revisiting β-Blockers in Patients with Acute Myocardial Infarction

NEXT ARTICLE

More From BioPortfolio on "Revisiting β-Blockers in Patients with Acute Myocardial Infarction"

Advertisement
Quick Search
Advertisement
Advertisement